Get the Stockscreener App
11.07
0.18%
-0.0322
Angiodynamic Inc stock is traded at $11.07, with a volume of 131.17K.
It is down -0.18% in the last 24 hours and up +17.87% over the past month.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
See More
Previous Close:
$11.10
Open:
$11.05
24h Volume:
131.17K
Relative Volume:
0.20
Market Cap:
$449.17M
Revenue:
$324.01M
Net Income/Loss:
$-192.37M
P/E Ratio:
-2.3154
EPS:
-4.78
Net Cash Flow:
$-23.46M
1W Performance:
-2.89%
1M Performance:
+17.87%
6M Performance:
+53.46%
1Y Performance:
+82.24%
1-Day Range:
$11.02
$11.16
1-Week Range:
$10.77
$11.54
52-Week Range:
$5.26
$13.50
Angiodynamic Inc Stock (ANGO) Company Profile
Name
Angiodynamic Inc
Sector
Industry
Phone
(518) 798-1215
Address
14 PLAZA DRIVE, LATHAM
Compare ANGO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ANGO
Angiodynamic Inc
|
11.06 | 449.17M | 324.01M | -192.37M | -23.46M | -4.78 |
|
ISRG
Intuitive Surgical Inc
|
587.34 | 209.89B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
229.09 | 68.23B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
90.17 | 45.33B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
236.31 | 34.84B | 4.93B | 1.25B | 1.38B | 8.47 |
|
WST
West Pharmaceutical Services Inc
|
321.29 | 23.97B | 2.88B | 499.60M | 321.60M | 6.74 |
Angiodynamic Inc Stock (ANGO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-05-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Sep-25-23 | Initiated | H.C. Wainwright | Buy |
| Apr-17-23 | Downgrade | Raymond James | Strong Buy → Outperform |
| Oct-15-21 | Upgrade | Canaccord Genuity | Hold → Buy |
| Aug-20-21 | Initiated | Oppenheimer | Perform |
| Nov-25-20 | Upgrade | Raymond James | Mkt Perform → Strong Buy |
| Apr-08-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-01-19 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-03-18 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Jan-05-18 | Downgrade | Craig Hallum | Buy → Hold |
| Apr-07-17 | Reiterated | Cantor Fitzgerald | Overweight |
| Mar-30-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
| Feb-08-17 | Initiated | Barclays | Equal Weight |
| Nov-04-16 | Initiated | Cantor Fitzgerald | Buy |
| Apr-08-16 | Resumed | Piper Jaffray | Neutral |
| Jan-08-16 | Reiterated | Canaccord Genuity | Buy |
| Nov-10-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-24-15 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jun-19-14 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-09-12 | Reiterated | Canaccord Genuity | Hold |
| Jun-25-12 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-15-11 | Upgrade | Canaccord Genuity | Hold → Buy |
| Jul-15-11 | Upgrade | Stifel Nicolaus | Hold → Buy |
| Jun-14-11 | Downgrade | Wedbush | Neutral → Underperform |
| Sep-08-10 | Reiterated | Wedbush | Neutral |
View All
Angiodynamic Inc Stock (ANGO) Latest News
BlackRock, Inc. Reduces Stake in AngioDynamics Inc - GuruFocus.com
Market Insight: Angiodynamic Inc (ANGO)’s Notable Drop, Closing at 11.04 - The Dwinnex
Angiodynamic Inc (ANGO) receives an Outperform rating from Oppenheimer - Knox Daily
Is it a good time to sell Palantir Technologies Inc [PLTR] shares after an insider sold 4,000 shares? - Knox Daily
Investing in CRH Plc (CRH): What You Must Know - Knox Daily
AngioDynamics Inc. (NASDAQ: ANGO) Reports Narrowed Net Loss and 8% Revenue Decline in Q2 FY2025 - HPBL
AngioDynamics, Inc.'s (NASDAQ:ANGO) Share Price Boosted 38% But Its Business Prospects Need A Lift Too - Simply Wall St
With 74% institutional ownership, AngioDynamics, Inc. (NASDAQ:ANGO) is a favorite amongst the big guns - Yahoo Finance
Assenagon Asset Management S.A. Reduces Holdings in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics, Inc. (NASDAQ:ANGO) Stock Position Raised by JPMorgan Chase & Co. - Defense World
Barclays PLC Boosts Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
**AngioDynamics (NASDAQ:ANGO) Reports Fiscal Second Quarter Results** - Defense World
AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin Declines - Yahoo Finance
AngioDynamics, Inc. (NASDAQ:ANGO) Q2 2025 Earnings Call Transcript - Insider Monkey
AngioDynamics Reports Growth and Advances NanoKnife System - Yahoo Finance
Institutional investors are AngioDynamics, Inc.'s (NASDAQ:ANGO) biggest bettors and were rewarded after last week's US$154m market cap gain - Simply Wall St
AngioDynamics (NASDAQ:ANGO) Reaches New 52-Week High After Better-Than-Expected Earnings - Defense World
AngioDynamics Inc (ANGO) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance
AngioDynamics, Inc. Reports Growth in Med Tech Segment - TipRanks
AngioDynamics Inc Reports Q2 Revenue of $73 Million, Exceeding E - GuruFocus.com
AngioDynamics: A Surgical Approach To Market Growth (NASDAQ:ANGO) - Seeking Alpha
AngioDynamics Hits New 52-Week High Following Strong Earnings Report – Market - HPBL
AngioDynamics hopes NanoKnife will become go-to prostate cancer treatment - Times Union
AngioDynamics Inc. (ANGO) reports earnings - Quartz
AngioDynamics: Fiscal Q2 Earnings Snapshot - The Washington Post
AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday - Benzinga
AngioDynamics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2024 - Marketscreener.com
AngioDynamics (ANGO) reports net loss for Q2 2025; sales drop 8% - AlphaStreet
What To Expect From AngioDynamics Inc (ANGO) Q2 2025 Earnings - GuruFocus.com
AngioDynamics to Showcase Revolutionary NanoKnife Cancer Treatment System at Investor Event - StockTitan
Geode Capital Management LLC Boosts Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
Barclays PLC Has $651,000 Stock Position in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics (NASDAQ:ANGO) vs. Orthofix Medical (NASDAQ:OFIX) Head-To-Head Contrast - Defense World
AngioDynamics, Inc. (NASDAQ:ANGO) Shares Sold by Franklin Resources Inc. - Defense World
Short Interest in AngioDynamics, Inc. (NASDAQ:ANGO) Declines By 12.3% - MarketBeat
State Street Corp Has $6.31 Million Stock Holdings in AngioDynamics, Inc. (NASDAQ:ANGO) - Defense World
AngioDynamics, Inc. (NASDAQ:ANGO) Stake Raised by Fmr LLC - Defense World
AngioDynamics Sets Date for Q2 Earnings, Unveils Special NanoKnife Investor Event - StockTitan
XTX Topco Ltd Takes $582,000 Position in AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
In-Depth Examination Of 4 Analyst Recommendations For AngioDynamics - Benzinga
There Is A Reason AngioDynamics, Inc.'s (NASDAQ:ANGO) Price Is Undemanding - Simply Wall St
AngioDynamics, Inc. (NASDAQ:ANGO) Stock Position Increased by BNP Paribas Financial Markets - MarketBeat
FDA clears AngioDynamics’ NanoKnife pulsed field ablation system for prostate cancer - Fierce Biotech
AngioDynamics Shares at 52-Week High After FDA Clears NanoKnife - Marketscreener.com
AngioDynamics Secures FDA Clearance for Breakthrough Prostate Cancer Treatment System After Strong Trial Results - StockTitan
Jacobs Levy Equity Management Inc. Sells 95,157 Shares of AngioDynamics, Inc. (NASDAQ:ANGO) - MarketBeat
AngioDynamics Port Defect Caused Infection, Ga. Man Says - Law360
Angiodynamic Inc Stock (ANGO) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.74%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):